News
How do you value Home Trial Support (Part 1): Site fragility and why it never went away
The $20 Million advantage: What decentralised trials are really worth
Bringing an ALS trial home – How far can you actually go?
Bringing a Duchenne trial home – How far can you actually go?
Beyond home visits: A site perspective on the future of DCT
Unlocking rare disease research: What the MHRA’s draft framework means for DCT
How to stop clinical trials failing before they start
Recruiting PNH trials faster – how Home Trial Support transforms rare disease research
Why clinical trial sites behave like a McDonald’s
Decentralised Clinical Trials: Why the right partner changes everything
